Asenapine and Imipramine Interaction

Drug interaction information between Asenapine and Imipramine.

Asenapine and Imipramine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Asenapine and Imipramine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Asenapine

Atypical Antipsychotic

Drug B

Imipramine

Tricyclic Antidepressant (TCA)

How They Interact

These medications do not significantly change how the body processes or reacts to one another.

FDA Label Information

7.2 Drugs Having No Clinically Important Interactions with Asenapine No dosage adjustment of asenapine is necessary when administered concomitantly with paroxetine (see Table 12 in Drug Interactions (7.1) for paroxetine dosage adjustment), imipramine, cimetidine, valporate, lithium, or a CYP3A4 inducer (e.g., carbamazepine, phenytoin, rifampin).

Frequently Asked Questions

What SPL severity band is on file for Asenapine + Imipramine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Imipramine has 20 labeled pairs on file vs Asenapine's 8. In the minor band specifically: Asenapine has 8 (also Paroxetine, Carbamazepine, Lithium, Rifampin); Imipramine has 17 (also Sertraline, Paroxetine, Flecainide, Propafenone).

What mechanism field is on file for Asenapine and Imipramine?

These medications do not significantly change how the body processes or reacts to one another.

Imipramine's labeled portfolio outnumbers Asenapine

SPL source-record counts only. This page's band is minor · classes on file: Asenapine (Atypical Antipsychotic); Imipramine (Tricyclic Antidepressant (TCA)).

Asenapine

0 major · 0 moderate · 8 minor · 8 total

Imipramine

0 major · 3 moderate · 17 minor · 20 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.